TJ Stopka, AT Estadt, G Leichtling, JC Schleicher… - Social Science & …, 2024 - Elsevier
Abstract Background In 2020, 2.8 million people required substance use disorder (SUD) treatment in nonmetropolitan or 'rural'areas in the US Among this population, only 10 …
AR Williams, SV Aronowitz, C Rowe… - The American Journal …, 2023 - Taylor & Francis
Background: Despite lifesaving medications such as buprenorphine and methadone, the majority of individuals with opioid use disorder (OUD) face access barriers to evidence …
Importance Transportation barriers have long been associated with poorer health outcomes; this burden is especially acute for individuals with opioid use disorder (OUD), a chronic …
Methadone treatment for opioid use disorder is not available in most suburban and rural US communities. We examined 2 options to expand methadone availability:(1) addiction …
B Corry, N Underwood, LJ Cremer… - Drug and Alcohol …, 2022 - Elsevier
Background Differences in availability of medications for opioid use disorder (MOUD) buprenorphine and methadone exist. Factors that may influence such differences in …
Rurality has served as a key concept in popular and scientific understandings of the US overdose crisis, with White, rural, and low-income areas thought to be most heavily affected …
Background This study aims to assess the association of community social vulnerability and community prescription opioid availability with individual non-fatal or fatal opioid overdose …
M Hassani, SD Young - Substance Use & Misuse, 2024 - Taylor & Francis
Opioid use disorder is a growing public health concern in the United States, causing economic burden and hindered by stigma. New forms of data, including location data, may …
Disparities in geographic access to medication for opioid use disorder (OUD) are well documented. Further, historical implications of systemic racism and of the longstanding War …